二甲双胍对PMMA颗粒作用下的间充质干细胞成骨分化的影响  

Effect of metformin on osteogenic differentiation of mesenchymal stem cells exposed to PMMA particles

作　　者：顾巧丽[1] 杨惠林[1] 施勤[1] GU Qiaoli;YANG Huilin;SHI Qin(Department of Orthopedic Surgery,the First Affiliated Hospital of Soochow University,Suzhou 215000,China)

机构地区：[1]苏州大学附属第一医院,江苏省苏州市215006

出　　处：《实用医学杂志》2017年第14期2263-2266,共4页The Journal of Practical Medicine

基　　金：国家自然科学基金项目(编号:81301341)

摘　　要：目的研究二甲双胍对PMMA颗粒刺激下人间充质干细胞成骨分化的影响。方法体外培养人胎盘间充质干细胞,CCK8法检测二甲双胍对细胞活力的影响;实时定量PCR分析成骨相关基因OCN,RNUX2及ALP表达;茜素红染色分析钙沉积状况;实时定量PCR分析e NOS表达。结果 PMMA能抑制人间充质干细胞活性,0.05 mmol/L二甲双胍能缓解PMMA对细胞活性的抑制;PMMA能抑制间充质干细胞成骨相关基因表达及矿物质沉积,加入二甲双胍后成骨基因表达升高,钙沉积增强;二甲双胍能上调间充质干细胞e NOS表达。结论二甲双胍能有效促进PMMA颗粒作用下的间充质干细胞成骨分化,其机制可能与上调e NOS表达有关。Objective To investigate the effect of metformin on the osteogenic differentiation of human mesenchymal stem cells exposed to PMMA particles.Methods Human placental mesenchymal stem cells were isolated and cultured in vitro.The effect of metformin with different concentrations on cell viability was determined by CCK8assay.The effect of metformin on the mRNA expression of osteogenic genes was detected by using real-time RT-PCR.Calcified nodules were stained by alizarin S.The effect of metformin on the expression of eNOS was also detected by using real-time RT-PCR.Results PMMA particles could inhibit the viability of mesenchymal stem cells.Metformin(0.05mmol/L)could promote the viability of mesenchymal stem cells exposed to PMMA particles.Metformin(0.05mmol/L)could increase the expression of osteogenic genes,including OCN,RNUX2,and ALP,in human mesenchymal stem cells exposed to PMMA particles.The calcium deposit was also increased after metformin treatment.Results of real?time RT?PCR showed that metformin could increase the expression of eNOS in human mesenchymal stem cells exposed to PMMA particles.Conclusions Metformin can increase the osteogenic differentiation of human mesenchymal stem cells exposed to PMMA particles,partially by inducing eNOS expression.

关 键 词：二甲双胍 PMMA 间充质干细胞 

分 类 号：R687.4[医药卫生—骨科学]